View this email in your browser
Monthly Newsletter – January 2021

Dear Friends and Colleagues:

We hope that your New Year is off to a strong and productive start. The first month of 2021 has been a busy one for the Anzu team and for our portfolio. 

Here's a quick preview of the highlights from this month:

  • Portfolio companies expanded their teams, boards of directors, and physical footprints to prepare for future growth, including 6KLiquid Instruments, and NTx
  • Several portfolio companies reached new intellectual property milestones, including NUBURU and InterVenn
  • Aspinity made a splash in the trade publications covering embedded hardware with the launch of its new Voice-First Evaluation Kit 
  • Anzu brought on several new team members across talent, investment and business development, with more to come in the following months

David Michael, David Seldin, and Whitney Haring-Smith


Former US Deputy Assistant Secretary of Defense Dr. Joe Felter joins 6K’s Advisory Board

6K, the world’s leading developer of microwave plasma technology for the production of advanced materials, announced that Dr. Joe Felter, a former senior Department of Defense official under then Secretary of Defense James Mattis, has joined its advisory board.

Dr. Felter plans to guide 6K’s strategy in working with the US Department of Defense and other Federal agencies for the innovation and deployment of advanced materials products to support the national interest of the US. He joins other industry luminaries including Magnus Rene, prior CEO ARCAM, and Robert Galyen, prior CTO CATL. 

To learn more about Dr. Felter and how he will help guide 6K, please read the press release here.

Liquid Instruments Enhances Executive Team and Board of Directors Ahead of Expansion to New Markets

Earlier this month, Liquid Instruments, an innovator in precision software-defined test and measurement instrumentation, announced that Doug Phillips, formerly of Texas Instruments, has been named Vice President of Marketing, along with the additions of former Los Alamos National Laboratory Director, Charles McMillan, Ph.D., and accomplished electronics industry executive, Saar Gillai, to its growing Board of Directors. 

Liquid Instruments CEO Daniel Shaddock said, “Doug comes to us with decades of experience in taking innovative technologies and developing a creative strategy to unlock their potential in the market, which will prove to be invaluable as our team furthers the mission to re-invent the test and measurement industry worldwide. Along with the new appointments of two well-respected and proven authorities within the R&D and technology sectors to our board, we are in an ideal position to establish ourselves as market leaders in modern instrumentation solutions.” 
To learn more about these new additions, read the press release here.

NTx Set to Launch Major Expansion in New Mexico

NTx, a bioinformatics and biomanufacturing company, recently received a LEDA grant from the New Mexico Economic Development Department to assist in its planned expansion into a new 25,000 square-foot research and production center in Rio Rancho, New Mexico. It will also aid in future job growth within the local community and further development of the facility to handle high-volume manufacturing and emergency response. 
In the recent press release announcing this move to Rio Rancho, Alicia J. Keyes, New Mexico Economic Development Cabinet Secretary said, “NTx is a company that launched in New Mexico and is now expanding in the state and adding high-paying jobs with assistance from LEDA. New Mexico has proven to be a recognized location for excellence in biosciences. The state investment in NTx will help build new partnerships in this industry and advance these innovative technologies."
This expansion story was covered locally in Albuquerque Business FirstRio Rancho ObserverSanta Fe New MexicanKOB TV and more. 
NUBURU Strengthens Blue Laser IP Portfolio with Seven New Patents Across 3D Printing and Material Processing
NUBURU, the leader in high power blue laser technology, announced that it has been awarded seven new patents earlier this month, further demonstrating its dominant intellectual property portfolio in visible laser technology and its applications across 3D printing and material processing. Its four new U.S. patents and three new foreign patents join the NUBURU foundational patent “3D Printing Devices and Methods” PCT/US14/35928, which was awarded in 16 countries with several other applications and continuations pending around the world, including with the U.S. patent office (2016/0067780).
The announcement was covered in several industry trade publications such as Semiconductor Today3D Printing IndustryIndustrial Laser SolutionsLaser Systems Europe and IP Watchdog
You can read the full press release here for specifics. 

InterVenn Receives Foundational Patent, CLIA Lab Certification to Develop Clinical Glycoproteomics Solutions

InterVenn Biosciences, the leader in glycoproteomics, recently announced the accomplishment of multiple milestones in advancing the world’s first glycoproteomics-based LDT(Lab-Developed Test). The company’s first diagnostic product, a noninvasive liquid biopsy test for ovarian cancer, will have final data from its initial clinical trial, V.O.C.A.L.™, in the first half of 2021. Additionally, InterVenn’s on-site laboratory recently received CLIA certification to make its tests available to the medical community. Finally, InterVenn was recently issued a key patent covering its core foundational technology IP on artificial intelligence and machine learning for the identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring. 
For full details on all of these critical achievements, see the press release here.

Aspinity Releases Analog Voice-First Evaluation Kit for Battery-Operated Devices

Aspinity, a pioneer in ultra-low-power analog machine learning (AnalogML™) processors, recently launched its Voice-First Evaluation Kit (EVK2), a complete hardware/software development kit that demonstrates its ultra-low-power edge processing solution for analog voice activity detection and preroll. This new kit enables Aspinity customers to easily integrate analog machine learning and analog data compression into battery-operated, voice-enabled devices, such as hearables/wearables, smart speakers and smart TV remotes, facilitating significant power savings—without compromising system accuracy. The announcement was widely covered in semiconductor and engineering trade journals such as Semiconductor Digest, eeNews Europe EmbeddedElectronic ProductsEE Journal and more.
You can get full details on the kit in the press release here.


Zeteo Tech Wins 2020 Tibbetts Award from the U.S. Small Business Administration

Zeteo Tech, a biodefense and medical device company, was one of just 38 companies selected for the Tibbetts Awards from the U.S. Small Business Administration. The Tibbetts Awards, named after Roland Tibbetts, the founder of the SBIR Program, honors the awardees for the exceptional successes they achieved through SBA’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Past Tibbetts awardees include: Qualcomm, 23andMe, Symantec and Broadcom.

“The Tibbetts Awards highlight our nation’s next generation of competitive creators who help push the U.S. economy into the future,” said SBA Administrator Jovita Carranza.

For the full list of winners and to learn more about the awards, see the press release here
OTI Lumionics Joins Quantum Industry Canada as a Founding Member

OTI Lumionics, a leader in the development of advanced materials for consumer electronics, recently joined Quantum Industry Canada as a founding member. 
Quantum Industry Canada (QIC) is a consortium of Canadian quantum technologies companies that includes developers of technologies for quantum computing, quantum communications and cryptography, quantum sensing and quantum-safe cryptography as well as companies developing applications of these technologies. The National Research Council of Canada (NRC) has identified Quantum technology as a $142.4 billion opportunity that could employ 229,000 Canadians by 2040. Canada is already a leader in quantum research and development, ranked first in per capita spending with over one billion dollars invested since 2005 (ranked #1 overall in quantum computing research, #5 overall).
Learn more about this consortium and its efforts in the press release here.
ImmunoScape Teams with Johns Hopkins University to Profile Immune Cells Fighting COVID-19, May Help Guide Next-Gen Vaccine Development 

lymphocyte A research team led by Johns Hopkins Medicine, in collaboration with ImmunoScape, a U.S.-Singapore biotechnology company, has published one of the most comprehensive characterizations to date of a critical contributor to protection against COVID-19. The study profiled the response of immune system cells called T lymphocytes (more commonly known as T cells) in people who have recovered from SARS-CoV-2 infection. 
The researchers, whose findings were posted online Jan. 11, 2021, in The Journal of Clinical Investigation, say that better defining which T cells interact with which specific portions of the SARS-CoV-2 virus, as well as how those interactions can provide long-lasting immunity against COVID-19, may help spur the development of the next generation of vaccines.
For full details on the findings, click here.
This past month, we were proud to welcome three new team members to the Anzu family:

Andrew Sandford: Executive in Residence

A microbiologist by education, Andrew Sandford has been building businesses around innovative offerings for over 20 years. In joining Anzu Partners as an Executive in Residence, Andrew will work with Anzu portfolio companies to develop strategies and commercial relationships, participate in diligence of prospective portfolio companies and work with the Anzu investment team in developing investment theses. 

Prior to joining Anzu, Andrew served as Vice President of Global Business Development, Biologics, for Catalent Pharma Solutions, a leading global provider of advanced services and technologies for drugs, biologics, and consumer health products. Earlier in his career, Andrew served as Vice President of Business Development for Selexis, Inc. where he established the U.S. subsidiary and was responsible for global transactional and strategic value creation. Andrew also worked for Cambrex Biopharma, which was latterly acquired by Lonza Biologics. He also spent nearly 10 years in Dow Chemical’s Ventures unit where he established and launched the highly successful Pfenex business unit.

He holds several professional leadership certifications, and is a graduate of the State University of New York College of Plattsburgh.

JQ Xi: Senior Associate, Manufacturing and Operations

JQ Xi is an accomplished business leader and entrepreneur. He has worked in a variety of industries including display, semiconductor, and optics. His experience has spanned across entrepreneurial innovation, start-up operation, business development, and business ecosystem creation. JQ has successfully led multiple projects to bring new and existing technology/product to the market. As a VP of Asia Business Development with Anzu Partners, JQ supports portfolio companies to develop business with a primary focus in Asia.

Previously, JQ was a strategic Partnership Manager at E Ink, where he led the effort to create and develop the North American healthcare business for the company. Prior to E Ink, JQ was a Program Manager at QD Vision, where he led the effort to develop business in Asia. He launched the first quantum dot TV in China by working with TCL. Before that, JQ was running his own company, Raydex Technology, Inc., a government contractor, primarily focusing on SBIR contracts and grants. He also worked at Corning on semiconductor laser devices.

JQ received his Ph.D. degree in Applied Physics from Rensselaer Polytechnic Institute, where his thesis work involved novel optical structure design and development for LEDs and solar cells to increase the efficiency. JQ received his BS degree from Fudan University in China. 

Kaitlyn Lagasca: Analyst, Talent

Kaitlyn Lagasca recently joined Anzu as an Analyst on the Talent team, supporting recruitment efforts across Anzu and the portfolio.

Kaitlyn is currently working towards her B.S. in Chemical Engineering with a Minor in Psychology at Northeastern University in Boston, Massachusetts.


Our portfolio companies are hiring! Browse the open roles here and learn more about joining our amazing teams.

We are looking for experts across Engineering, Life Sciences, Sales and Business Development, Product, Operations, and Marketing and Communications.


To stay up to date on the latest news from both Anzu and our portfolio companies, follow us on social media.

Twitter Twitter
LinkedIn LinkedIn

Copyright © 2021 Anzu Partners, All rights reserved.

You are receiving this email because you requested to be added to Anzu Partners' monthly newsletter distribution list. 

We take the privacy of our subscribers very seriously. View our Privacy Policy.

Would you like to change how you receive these emails?
You can update your preferences or unsubscribe from this list.